Sign in

CIK 0001231457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

GENELUX Corp

Sign in to watch
Ticker
GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 805-267-9889
Business address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$155,693
in 6 filings

Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-09-11 Mirabelli Mary Director Grant or award +3,460 4,460
2023-09-11 Mirabelli Mary Director Grant or award · Stock Option (Right to Buy) +4,397 4,397
2023-09-11 Tyree James L Director Grant or award +3,460 12,460
2023-09-11 Tyree James L Director Grant or award · Stock Option (Right to Buy) +4,397 4,397
2023-09-11 Thomas John Director Grant or award +3,460 482,460
2023-09-11 Thomas John Director Grant or award · Stock Option (Right to Buy) +4,397 4,397
2023-09-11 Smither John W Director Grant or award +6,920 7,820
2023-09-11 Smither John W Director Grant or award · Stock Option (Right to Buy) +8,447 8,447
2023-09-11 Szalay Aladar 10% owner Sale −9,331 $21.39 $200K 122,885
2023-09-11 Szalay Aladar 10% owner Sale −23,020 $22.55 $519K 99,865
2023-09-11 Ryder Sean General Counsel Grant or award · Stock Option (right to buy) +40,000 40,000
2023-09-11 Samuelson Doug Vice President, Finance Grant or award · Stock Option (right to buy) +40,000 40,000
2023-09-11 Yu Yong VP, Clinical Trial Operations Grant or award · Stock Option (right to buy) +65,000 65,000
2023-09-11 Cappello Joseph VP, Pharmaceutical Development Grant or award · Stock Option (right to buy) +65,000 65,000
2023-09-11 Smalling Ralph Head of Regulatory Grant or award +10,000 12,065
2023-09-11 Smalling Ralph Head of Regulatory Grant or award · Stock Option (right to buy) +54,000 54,000
2023-09-11 Jewett Caroline Head of Quality Grant or award +20,000 21,135
2023-09-11 Jewett Caroline Head of Quality Grant or award · Stock Option (right to buy) +88,000 88,000
2023-09-11 Zak Lourie S. Chief Financial Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2023-09-08 Szalay Aladar 10% owner Sale −13,672 $22.78 $311K 143,375

Page 14 of 16 · 315 trades